These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 36146815)

  • 21. Determinants of Spike infectivity, processing, and neutralization in SARS-CoV-2 Omicron subvariants BA.1 and BA.2.
    Pastorio C; Zech F; Noettger S; Jung C; Jacob T; Sanderson T; Sparrer KMJ; Kirchhoff F
    Cell Host Microbe; 2022 Sep; 30(9):1255-1268.e5. PubMed ID: 35931073
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Real-Time RT-PCR Allelic Discrimination Assay for Detection of N501Y Mutation in the Spike Protein of SARS-CoV-2 Associated with B.1.1.7 Variant of Concern.
    Abdulnoor M; Eshaghi A; Perusini SJ; Broukhanski G; Corbeil A; Cronin K; Fittipaldi N; Forbes JD; Guthrie JL; Kus JV; Li Y; Majury A; Mallo GV; Mazzulli T; Melano RG; Olsha R; Sullivan A; Tran V; Patel SN; Allen VG; Gubbay JB
    Microbiol Spectr; 2022 Feb; 10(1):e0068121. PubMed ID: 35170989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SpikeSeq: A rapid, cost efficient and simple method to identify SARS-CoV-2 variants of concern by Sanger sequencing part of the spike protein gene.
    Jørgensen TS; Pedersen MS; Blin K; Kuntke F; Salling HK; Marvig RL; Michaelsen TY; Albertsen M; Larsen H
    J Virol Methods; 2023 Feb; 312():114648. PubMed ID: 36368344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Biological Functions and Clinical Significance of SARS-CoV-2 Variants of Corcern.
    Akkız H
    Front Med (Lausanne); 2022; 9():849217. PubMed ID: 35669924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative analysis of SARS-CoV-2 Omicron BA.2.12.1 and BA.5.2 variants.
    Ong CP; Ye ZW; Tang K; Liang R; Xie Y; Zhang H; Qin Z; Sun H; Wang TY; Cheng Y; Chu H; Chan JF; Jin DY; Yuan S
    J Med Virol; 2023 Jan; 95(1):e28326. PubMed ID: 36411262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emergency SARS-CoV-2 Variants of Concern: Novel Multiplex Real-Time RT-PCR Assay for Rapid Detection and Surveillance.
    Chung HY; Jian MJ; Chang CK; Lin JC; Yeh KM; Chen CW; Hsieh SS; Hung KS; Tang SH; Perng CL; Chang FY; Wang CH; Shang HS
    Microbiol Spectr; 2022 Feb; 10(1):e0251321. PubMed ID: 35196812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of SARS-CoV-2 Omicron on Rapid Antigen Testing Developed for Early-Pandemic SARS-CoV-2 Variants.
    Leuzinger K; Roloff T; Egli A; Hirsch HH
    Microbiol Spectr; 2022 Aug; 10(4):e0200622. PubMed ID: 35943268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Origin and Reversion of Omicron Core Mutations in the Evolution of SARS-CoV-2 Genomes.
    Zhao X; Qin L; Ding X; Zhang Y; Niu X; Gao F; Jiang T; Chen L
    Viruses; 2022 Dec; 15(1):. PubMed ID: 36680069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In Silico Genome Analysis Reveals the Evolution and Potential Impact of SARS-CoV-2 Omicron Structural Changes on Host Immune Evasion and Antiviral Therapeutics.
    Chauhan D; Chakravarty N; Jeyachandran AV; Jayakarunakaran A; Sinha S; Mishra R; Arumugaswami V; Ramaiah A
    Viruses; 2022 Nov; 14(11):. PubMed ID: 36366559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Challenges of the Omicron (B.1.1.529) Variant and Its Lineages: A Global Perspective.
    Mohapatra RK; Kandi V; Verma S; Dhama K
    Chembiochem; 2022 May; 23(9):e202200059. PubMed ID: 35322516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different Neutralization Profiles After Primary SARS-CoV-2 Omicron BA.1 and BA.2 Infections.
    Medits I; Springer DN; Graninger M; Camp JV; Höltl E; Aberle SW; Traugott MT; Hoepler W; Deutsch J; Lammel O; Borsodi C; Puchhammer-Stöckl E; Zoufaly A; Weseslindtner L; Aberle JH; Stiasny K
    Front Immunol; 2022; 13():946318. PubMed ID: 35928813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of Entry Pathways, Species-Specific Angiotensin-Converting Enzyme 2 Residues Determining Entry, and Antibody Neutralization Evasion of Omicron BA.1, BA.1.1, BA.2, and BA.3 Variants.
    Neerukonda SN; Wang R; Vassell R; Baha H; Lusvarghi S; Liu S; Wang T; Weiss CD; Wang W
    J Virol; 2022 Sep; 96(17):e0114022. PubMed ID: 36000843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Temperature Influences the Interaction between SARS-CoV-2 Spike from Omicron Subvariants and Human ACE2.
    Gong SY; Ding S; Benlarbi M; Chen Y; Vézina D; Marchitto L; Beaudoin-Bussières G; Goyette G; Bourassa C; Bo Y; Medjahed H; Levade I; Pazgier M; Côté M; Richard J; Prévost J; Finzi A
    Viruses; 2022 Sep; 14(10):. PubMed ID: 36298733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bayesian Molecular Dating Analyses Combined with Mutational Profiling Suggest an Independent Origin and Evolution of SARS-CoV-2 Omicron BA.1 and BA.2 Sub-Lineages.
    Kumar N; Kaushik R; Singh A; Uversky VN; Zhang KYJ; Sahu U; Bhatia S; Sanyal A
    Viruses; 2022 Dec; 14(12):. PubMed ID: 36560768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Bispecific Antibody Targeting RBD and S2 Potently Neutralizes SARS-CoV-2 Omicron and Other Variants of Concern.
    Yuan M; Chen X; Zhu Y; Dong X; Liu Y; Qian Z; Ye L; Liu P
    J Virol; 2022 Aug; 96(16):e0077522. PubMed ID: 35916510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Baseline Sequencing Surveillance of Public Clinical Testing, Hospitals, and Community Wastewater Reveals Rapid Emergence of SARS-CoV-2 Omicron Variant of Concern in Arizona, USA.
    Smith MF; Holland SC; Lee MB; Hu JC; Pham NC; Sullins RA; Holland LA; Mu T; Thomas AW; Fitch R; Driver EM; Halden RU; Villegas-Gold M; Sanders S; Krauss JL; Nordstrom L; Mulrow M; White M; Murugan V; Lim ES
    mBio; 2023 Feb; 14(1):e0310122. PubMed ID: 36622143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Heterologous Challenge Rescues the Attenuated Immunogenicity of SARS-CoV-2 Omicron BA.1 Variant in Syrian Hamster Model.
    Ma J; Liu X; Zhou M; Chen P; Chen R; Wang J; Zhu H; Wu K; Ye J; Zhang Y; Yuan Q; Tang Q; Yuan L; Cheng T; Guan Y; Xia N
    J Virol; 2023 Feb; 97(2):e0168422. PubMed ID: 36651747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural Study of SARS-CoV-2 Antibodies Identifies a Broad-Spectrum Antibody That Neutralizes the Omicron Variant by Disassembling the Spike Trimer.
    Zhan W; Tian X; Zhang X; Xing S; Song W; Liu Q; Hao A; Hu Y; Zhang M; Ying T; Chen Z; Lan F; Sun L
    J Virol; 2022 Aug; 96(16):e0048022. PubMed ID: 35924918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of Spike Mutations in SARS-CoV-2 Variants of Concern on Human or Animal ACE2-Mediated Virus Entry and Neutralization.
    Kim Y; Gaudreault NN; Meekins DA; Perera KD; Bold D; Trujillo JD; Morozov I; McDowell CD; Chang KO; Richt JA
    Microbiol Spectr; 2022 Jun; 10(3):e0178921. PubMed ID: 35638818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In silico evaluation of the impact of Omicron variant of concern sublineage BA.4 and BA.5 on the sensitivity of RT-qPCR assays for SARS-CoV-2 detection using whole genome sequencing.
    Sharma D; Notarte KI; Fernandez RA; Lippi G; Gromiha MM; Henry BM
    J Med Virol; 2023 Jan; 95(1):e28241. PubMed ID: 36263448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.